| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biosimilar tocilizumab—better access and lower cost?
|
Goll, Guro L
|
|
|
6 |
1 |
p. e6-e8
|
artikel
|
| 2 |
Can contextual factors improve clarity of the results from clinical trials of low back pain?
|
Dougherty, Paul
|
|
|
6 |
1 |
p. e2-e3
|
artikel
|
| 3 |
Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial
|
Leng, Xiaomei
|
|
|
6 |
1 |
p. e40-e50
|
artikel
|
| 4 |
Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH Across Speciality Collaboration (HiHASC) consensus guideline
|
Cox, Miriam F
|
|
|
6 |
1 |
p. e51-e62
|
artikel
|
| 5 |
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial
|
Hanberg, Jennifer S
|
|
|
6 |
1 |
p. e21-e30
|
artikel
|
| 6 |
Effectiveness of a fourth mRNA dose among individuals with systemic autoimmune rheumatic diseases during the Omicron era
|
Widdifield, Jessica
|
|
|
6 |
1 |
p. e3-e4
|
artikel
|
| 7 |
Hip-focused physical therapy versus spine-focused physical therapy for older adults with chronic low back pain at risk for mobility decline (MASH): a multicentre, single-masked, randomised controlled trial
|
Hicks, Gregory E
|
|
|
6 |
1 |
p. e10-e20
|
artikel
|
| 8 |
Is low-dose naltrexone for fibromyalgia another treatment disappointment?
|
Häuser, Winfried
|
|
|
6 |
1 |
p. e5-e6
|
artikel
|
| 9 |
Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial
|
Due Bruun, Karin
|
|
|
6 |
1 |
p. e31-e39
|
artikel
|
| 10 |
Research in Brief
|
Thorley, Jennifer
|
|
|
6 |
1 |
p. e9
|
artikel
|
| 11 |
Urgent reform needed for homecare medicines services
|
The Lancet Rheumatology,
|
|
|
6 |
1 |
p. e1
|
artikel
|
Tijdschrift beschrijving